How to evaluate the quality and standardization level of tumor tissue microarrays

Core Dimensions of Quality Assessment

The quality of a tumor tissue microarray is not measured solely by whether the spot array is intact, but should be comprehensively assessed by examining tissue morphology preservation, array arrangement accuracy, section thickness uniformity, staining consistency, and completeness of clinical information. A high-quality microarray should be able to provide reproducible detection results across different batch experiments while retaining sufficient histological features for pathological interpretation.

In routine quality control, it is typically necessary for pathology professionals to perform sampling microscopy on the microarray to confirm whether individual tissue spots exhibit detachment, folding, fragmentation, or positional deviation. If the tissue morphology at a particular spot does not meet requirements, it should be recorded and excluded to avoid affecting statistical conclusions.

Key Points of Tissue Fixation and Microarray Preparation

Tissue fixation is a critical step affecting antigenicity and nucleic acid integrity. Delayed fixation, insufficient fixation time, or excessive fixation duration can all lead to protein degradation or excessive cross-linking, affecting subsequent immunohistochemistry or in situ hybridization signals. It is generally recommended to use neutral formalin for fixation as soon as possible after sample excision, while maintaining a reasonable ratio of fixative volume to tissue volume.

Representative regions should be selected from donor paraffin blocks, avoiding necrotic, hemorrhagic, and fibrotic areas.

The core needle drilling position must be clearly marked on the donor section and reviewed by a pathologist.

During recipient paraffin block preparation, air bubbles and cracks should be avoided to ensure tight integration between the core and the recipient block.

These operational details directly affect the integrity and staining quality during microarray sectioning.

Staining Consistency and Data Reproducibility

One of the main advantages of tumor tissue microarrays is the consistency of experimental conditions; however, if the microarray itself has uneven thickness or significant differences in tissue spot fixation status, variations in staining intensity may still occur. To assess consistency, multiple replicate spots and control spots can be included in the microarray to calculate the variation in staining intensity for the same tissue or cell type.

When conditions permit, microarray sections from different batches can be stained for the same marker to compare positive rates or scoring stability. If variation is substantial, the causes should be investigated from aspects such as section thickness, reagent lot, retrieval conditions, and scanning interpretation parameters. Digital pathology scanning and image analysis software can also help reduce subjective differences in manual interpretation.

Ethical Compliance and Sample Traceability

Tumor tissue microarrays often involve patient tissue samples and clinical information, and must comply with informed consent, ethical review, and privacy protection requirements. Sample source, collection time, processing procedures, and clinical follow-up data should be traceable; however, when providing externally or used for collaborative research, de-identification should be performed.

Establishing a full-process sample recording system helps to quickly identify problematic batches when quality disputes arise or research results need to be reviewed. For microarrays involving cross-institutional sharing, the scope of use, data management responsibilities, and authorship principles should be clearly defined.

Recommendations for Establishing Internal Quality Control Procedures

It is recommended that biobanks or pathology platforms integrate tumor tissue microarray quality control into routine workflows: review donor paraffin block quality before microarray preparation; perform preliminary morphological screening immediately after preparation; conduct random sampling for target marker pre-staining; set up intra-batch and inter-batch controls during formal experiments; and preserve stained section images and analysis records after experiments are completed.

Through continuous accumulation of quality control data, standardized operating procedures suitable for one's own institution can be gradually developed, improving the reliability of microarray products and the credibility of research data.